Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Classical hematology 2Plasma cell 1Other hematologic neoplasm 1Myeloid 1

Conditions

Leukemia, Myeloid, Acute 148Myelodysplastic Syndromes 116Leukemia 115Precursor Cell Lymphoblastic Leukemia-Lymphoma 95Lymphoma 86Lymphoma, Non-Hodgkin 80Multiple Myeloma 74Hodgkin Disease 68Leukemia, Lymphocytic, Chronic, B-Cell 61Lymphoma, Large B-Cell, Diffuse 52Myeloproliferative Disorders 51Congenital Abnormalities 51Leukemia, Myeloid, Chronic-Phase 50Lymphoma, Follicular 47Leukemia, Myeloid, Accelerated Phase 47Neoplasms, Plasma Cell 46Lymphoma, Mantle-Cell 43Leukemia, Myelomonocytic, Chronic 43Burkitt Lymphoma 42Lymphoma, B-Cell, Marginal Zone 41Lymphoma, Large-Cell, Immunoblastic 39Leukemia, Myelogenous, Chronic, BCR-ABL Positive 39Blast Crisis 39Primary Myelofibrosis 36Recurrence 33Anemia, Refractory, with Excess of Blasts 33Hematologic Neoplasms 32Myelodysplastic-Myeloproliferative Diseases 31Graft vs Host Disease 31Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 28

Interventions

eltrombopag 9avatrombopag 6Platelet Transfusion 6romiplostim 4Tranexamic Acid 3Radiotherapy 3Cytarabine 3oprelvekin 2hetrombopag 2Tretinoin 2Peripheral Blood Stem Cell Transplantation 2Filgrastim 2Cyclophosphamide 2Carboplatin 2Busulfan 2Amplified Fragment Length Polymorphism Analysis 2sodium thiosulfate 1siltuximab 1raltitrexed 1pegfilgrastim 1ofatumumab 1niraparib 1leridistim 1fludarabine phosphate 1fludarabine 1etoposide phosphate 1apixaban 1Vorinostat 1Vitamin B 12 1Transplantation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Thrombocytopenia × Busulfan × Clear all
NCT03303950 2022-05-05

Allogeneic Stem Cell Transplantation for Multiple Myeloma and Myelofibrosis

University of Utah

Phase 2 Terminated
6 enrolled 17 charts
Classical hematologyMyeloidPlasma cell

Anemia, Multiple Myeloma, Thrombocytopenia, Primary Myelofibrosis

NCT00305708 2012-11-12

Busulfan, Antithymocyte Globulin, and Fludarabine Followed By a Donor Stem Cell Transplant in Treating Young Patients With Blood Disorders, Bone Marrow Disorders, Chronic Myelogenous Leukemia in First Chronic Phase, or Acute Myeloid Leukemia in First Remission

University of California, San Francisco

Phase 1/2 Completed
40 enrolled
Classical hematologyOther hematologic neoplasm

Congenital amegakaryocytic thrombocytopenia, Neutropenia, Severe Congenital, Autosomal Recessive 3, Fanconi Anemia, Leukemia, Thrombocytopenia, Leukemia, Myeloid, Chronic-Phase, Anemia, Diamond-Blackfan

Data powered by HemOnc (CC BY 4.0) Colophon âš¡